Follow us on:
Breaking News
January 7, 2026
Your Weekly Update on the Orthopedic Device Industry
Breaking News
Teleflex_ODT_Leaderboard_0126

Setting, Technique, and Technology: Drivers of Orthopedic Design in 2026

 
Setting, Technique, and Technology: Drivers of Orthopedic Design in 2026

Innovation now happens at the intersection of clinical insight, data science, and manufacturing—a dynamic that will define design in the coming year.
Read More >>

Today's Top Headlines

OEM News

mediCAD Releases Updated Surgical Planning Software

mediCAD 8 automatically detects image parameters such as orientation and scale, displaying only the relevant tools for each case.

Financial/Business
OEM News

VB Spine Completes Acquisition of Stryker’s French Spine Facility

The Cestas facility will play a key role in VB Spine’s global manufacturing strategy because of its state-of-the-art operations and technical capabilities.

Financial/Business

Overture Orthopaedics Marks Sales Milestone

The company's OvertureTi Knee Resurfacing System implants are designed as an alternative to both arthroplasty and biological repair options.

ODT Forum 2026_Box AD_042226

OEM News

RevBio Wins FDA Nod for Dental Trial of Regenerative Bone Glue

The trial will assess the TETRANITE regenerative bone adhesive to perform dental ridge augmentation procedures.

OEM News

Vicarious Surgical Teams Up With Software Development Firm

The unnamed partner has begun onboarding through a structured transition plan that maintains continuity across all active workstreams.

OEM News

Cutera’s truFlex Wins FDA Nod for Rehab, Recovery, and Muscle Wellness

truFlex was introduced in 2019 and is powered by the company’s proprietary Multi-Directional Stimulation (MDS) technology.

Columns

Lasers: Changing Orthopedic Implant Design and Manufacturing

Lasers can enable orthopedic implant designers and manufacturers to create devices with functional surfaces that often outperform older state-of-the-art technology

Featured Resources

Solution Center SPOTLIGHT

Evonik Industries AG

Evonik offers a broad portfolio of biomaterials for medical devices that meet the highest standards of biocompatibility, biostability, and performance. Our biomaterials support innovation in medical devices, from short-term to long-term implantable devices, while our bioresorbable medical polymers enable controlled degradation, opening further possibilities for medical device applications. With decades of experience in polymer science and medical-grade material development, Evonik is a trusted partner to the global medical device industry. We offer a comprehensive range of high-performance biomaterials, including RESOMER®, VESTAKEEP®, and VECOLLAN®, each tailored to specific medical applications. Our team supports customers with customization, regulatory guidance, and global technical support, helping accelerate product development from concept to market.